Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion type Assertion NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_head.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion description "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion evidence source_evidence_literature NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion SIO_000772 16983080 NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion wasDerivedFrom befree-20150227 NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.
- NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_assertion wasGeneratedBy ECO_0000203 NP384536.RAB7xqEo5g9tZXG6KiYD-Ty7825Lm0zjioUHzAQavoEFY130_provenance.